Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8490826rdf:typepubmed:Citationlld:pubmed
pubmed-article:8490826lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8490826lifeskim:mentionsumls-concept:C0278884lld:lifeskim
pubmed-article:8490826lifeskim:mentionsumls-concept:C0023216lld:lifeskim
pubmed-article:8490826lifeskim:mentionsumls-concept:C0025241lld:lifeskim
pubmed-article:8490826lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:8490826lifeskim:mentionsumls-concept:C1579762lld:lifeskim
pubmed-article:8490826lifeskim:mentionsumls-concept:C0009491lld:lifeskim
pubmed-article:8490826lifeskim:mentionsumls-concept:C0086960lld:lifeskim
pubmed-article:8490826lifeskim:mentionsumls-concept:C1514923lld:lifeskim
pubmed-article:8490826pubmed:issue10lld:pubmed
pubmed-article:8490826pubmed:dateCreated1993-6-15lld:pubmed
pubmed-article:8490826pubmed:abstractTextForty-two patients with measurable recurrent melanoma of the lower limb were treated according to a double-perfusion schedule.lld:pubmed
pubmed-article:8490826pubmed:languageenglld:pubmed
pubmed-article:8490826pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490826pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8490826pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490826pubmed:statusMEDLINElld:pubmed
pubmed-article:8490826pubmed:monthMaylld:pubmed
pubmed-article:8490826pubmed:issn0008-543Xlld:pubmed
pubmed-article:8490826pubmed:authorpubmed-author:van DongenJ...lld:pubmed
pubmed-article:8490826pubmed:authorpubmed-author:KroonB BBBlld:pubmed
pubmed-article:8490826pubmed:authorpubmed-author:van GeelA NANlld:pubmed
pubmed-article:8490826pubmed:authorpubmed-author:FranklinH RHRlld:pubmed
pubmed-article:8490826pubmed:authorpubmed-author:EggermontA...lld:pubmed
pubmed-article:8490826pubmed:authorpubmed-author:KlaaseJ MJMlld:pubmed
pubmed-article:8490826pubmed:issnTypePrintlld:pubmed
pubmed-article:8490826pubmed:day15lld:pubmed
pubmed-article:8490826pubmed:volume71lld:pubmed
pubmed-article:8490826pubmed:ownerNLMlld:pubmed
pubmed-article:8490826pubmed:authorsCompleteYlld:pubmed
pubmed-article:8490826pubmed:pagination2990-4lld:pubmed
pubmed-article:8490826pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:meshHeadingpubmed-meshheading:8490826-...lld:pubmed
pubmed-article:8490826pubmed:year1993lld:pubmed
pubmed-article:8490826pubmed:articleTitleA retrospective comparative study evaluating the results of a single-perfusion versus double-perfusion schedule with melphalan in patients with recurrent melanoma of the lower limb.lld:pubmed
pubmed-article:8490826pubmed:affiliationDepartment of Surgery, The Netherlands Cancer Institute (Antoni van Leeuwenhoek Huis), Amsterdam.lld:pubmed
pubmed-article:8490826pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8490826pubmed:publicationTypeComparative Studylld:pubmed